300453SZSE
🚨 Material Event

Indicative Announcement on the Prospectus for Issuance of Convertible Corporate Bonds to Unspecified Targets by Jiangxi Sanxin Medtec Co., Ltd.

Sanxin Medical Co., Ltd.··19 pages

✨ AI Summary

Jiangxi Sanxin Medtec Co., Ltd. has received regulatory approval to issue 530 million RMB in convertible corporate bonds. The issuance will prioritize existing shareholders on the equity registration date of August 3, 2026, with the remaining balance offered to public investors via the Shenzhen Stock Exchange. The bonds have a six-year term with a tiered coupon rate ranging from 0.20% to 1.80%. Proceeds will be managed by the lead underwriter, Guojin Securities.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Stock Code: 300453 Stock Abbreviation: Sanxin Medtec Announcement No.: 2026-046

Jiangxi Sanxin Medtec Co., Ltd.

Indicative Announcement on the Prospectus for Issuance of Convertible Corporate Bonds to Unspecified Targets

Sponsor (Lead Underwriter): Guojin Securities Co., Ltd.

Special Notice:

Jiangxi Sanxin Medtec Co., Ltd. (hereinafter referred to as "Sanxin Medtec", "the Company", or "the Issuer") has received approval from the China Securities Regulatory Commission (CSRC) via document Zheng Jian Xu Ke [2026] No. 1311 to issue 530,000,000 RMB in convertible corporate bonds (hereinafter referred to as "this issuance").

The convertible bonds will be offered for priority placement to existing shareholders registered with the Shenzhen Branch of China Securities Depository and Clearing Corporation Limited (hereinafter "CSDC Shenzhen Branch") after the close of the market on the equity registration date (August 3, 2026, T-1 day). The balance after priority placement (including portions waived by original shareholders) will be issued to social public investors via the Shenzhen Stock Exchange (hereinafter "SZSE") trading system.

The full text of the prospectus and related materials for this issuance can be found on the Juchao Information website (http://www.cninfo.com.cn).

I. Basic Information on the Issuance

(I) Type of Securities

The securities issued are convertible corporate bonds that can be converted into the Company's A-shares. These bonds and the future converted A-shares will be listed on the ChiNext board of the Shenzhen Stock Exchange.

(II) Issuance Scale

The total proceeds from this issuance are 530,000,000 RMB, with an issuance quantity of 5.3 million units.

(III) Face Value and Issuance Price

The convertible bonds are issued at par value, with a face value of 100 RMB per unit.

(IV) Issuance Method and Targets

  1. Issuance Method

The Sanxin Convertible Bonds will be offered for priority placement to existing shareholders registered with the CSDC Shenzhen Branch after the close of the market on the equity registration date (August 3, 2026, T-1 day). The balance after priority placement will be issued to social public investors via the SZSE trading system. Any portion of the 530,000,000 RMB subscription not met will be underwritten by the sponsor (lead underwriter).

  1. Issuance Targets

(1) Priority placement to existing shareholders: All shareholders of the Issuer registered with the CSDC Shenzhen Branch after the close of the market on the equity registration date (August 3, 2026, T-1 day) as announced.

(2) Online issuance: Natural persons, legal entities, securities investment funds, and other investors complying with laws and regulations who hold securities accounts with the CSDC Shenzhen Branch (excluding those prohibited by national laws and regulations). Natural persons must have activated trading permissions for convertible bonds issued to unspecified targets in accordance with the "Notice on Improving Matters Related to Investor Suitability Management for Convertible Corporate Bonds (2025 Revision)" (Shen Zheng Shang [2025] No. 223).

(3) The proprietary accounts of the sponsor (lead underwriter) for this issuance may not participate in the subscription.

(V) Underwriting Method and Period

The convertible bonds are underwritten by the sponsor (lead underwriter) on a standby underwriting basis. The sponsor assumes responsibility for the balance of any subscription shortfall below 530,000,000 RMB. The underwriting period is from July 31, 2026 (T-2 day) to August 10, 2026 (T+4 day).

(VI) Timeline for the Issuance

DateTrading DayIssuance Arrangement
July 31, 2026 (Friday)T-2 dayDisclosure of Prospectus, summary, and related announcements
August 3, 2026 (Monday)T-1 dayOnline roadshow; Equity registration date for existing shareholders
August 4, 2026 (Tuesday)T dayDisclosure of issuance announcement; Priority placement and online subscription
August 5, 2026 (Wednesday)T+1 dayDisclosure of subscription results; Online lottery draw
August 6, 2026 (Thursday)T+2 dayDisclosure of winning numbers; Payment of subscription funds
August 7, 2026 (Friday)T+3 daySponsor determines final allocation and underwriting amount
August 10, 2026 (Monday)T+4 dayDisclosure of issuance results; Proceeds transferred to company account

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.